SRL_Diagnostics

Agilus Diagnostics

Agilus Diagnostics

Indian diagnostics chain


Agilus Diagnostics Limited (formerly known as SRL Limited) is an Indian multinational diagnostics company providing diagnostic services in pathology and radiology. Agilus Diagnostics has its headquarters and corporate office in Gurgaon.

Quick Facts Formerly, Company type ...

History

The company was founded in 1995 by brothers Shivinder Mohan Singh and Malvinder Mohan Singh as SRL Ranbaxy, a division of Ranbaxy Laboratories.[5] It became the first pathology company in India to receive accreditation from National Accreditation Board.[6]

In 2008, SRL Ranbaxy was renamed as Super Religare Laboratories.[7]

In 2010, SRL acquired Piramal Diagnostic Services and its network of 107 laboratories from Piramal Healthcare for 600 crore.[8]

In 2011, Fortis Healthcare completed the acquisition of 74.59% stake in SRL.[9] After being acquired by Fortis, the company rebranded itself as SRL Diagnostics.[10]

In 2021, SRL acquired the remaining stake in its Kerala-based joint venture, DDRC, for 350 crore. With the addition of DDRC's 220 labs to its lab network, SRL became the biggest pathology lab chain in India with a total of 430 labs.[11]

In 2023, SRL Diagnostics changed its name to Agilus Diagnostics.[12]

Operations

Agilus has two reference labs one in Goregaon (Mumbai), and one in Gurgaon (Haryana), India. The company has more than 418 networking laboratories,[13] including four "Centers of Excellence", 26 radiology/imaging centers, 40 NABL accredited, and four CAP-accredited labs and a footprint spanning over 9000 collection points in India.[14] Along with this, the company also has large labs in Dubai, Sri Lanka and Nepal, and about 70 different collection points in various countries outside India.[15]

Agilus Diagnostics claims to offer more than 3,500 different tests in pathology, radiology, wellness, occupational health and clinical trials and also carries out more than 107,000 tests in a day.[16] Agilus Diagnostics operates diagnostic centres, collection centres, and laboratories. Agilus Diagnostics also offers tests in pathology covering biochemistry, immunology, herpetology, clinical pathology, histopathology and immunohistochemistry, microbiology, molecular biology, cytogenetics, and flow cytometry.[17]


References

  1. Unnikrishnan, C. H. (22 August 2008). "SRL Ranbaxy mulls merger with Fortis Health". Mint. Retrieved 9 January 2023.
  2. V, Narayanan (9 June 2022). "SRL Diagnostics to set up central reference lab in Chennai". The Hindu Businessline. Retrieved 9 January 2023.
  3. "SRL Limited". CRISIL. Retrieved 6 January 2023.
  4. "Agilus Diagnostics withdraws IPO plans, says SEBI". Moneycontrol. 22 February 2024. Retrieved 23 February 2024.
  5. Kandhari, Ruhi (7 May 2019). "Can IHH help SRL finally scratch its 10-year itch?". The Ken. Retrieved 9 January 2023.
  6. D'Silva, Jeetha. "SRL Ranbaxy plans to set up four more labs". The Economic Times. Retrieved 9 January 2023.
  7. "SRL Ranbaxy rechristened as Super Religare Lab". mint. 29 September 2008. Retrieved 9 January 2023.
  8. "Piramal Healthcare completes sale of diagnostics arm to SRL". Business Standard India. 21 August 2010. Retrieved 9 January 2023.
  9. "Fortis completes acquisition of 74.59% stake in SRL". Business Standard India. 12 May 2011. Retrieved 9 January 2023.
  10. Vijayraghavan, Kala. "Super Religare Laboratories rechristens itself as 'SRL Diagnostics'; launches new logo". The Economic Times. Retrieved 9 January 2023.
  11. Jayan, T. V. (30 March 2021). "SRL becomes India's largest pathlab chain after acquiring DDRC". The Hindu Businessline. Retrieved 9 January 2023.
  12. Pilla, Viswanath (2023-05-27). "SRL Diagnostics rebrands as Agilus Diagnostics". The Economic Times. ISSN 0013-0389. Retrieved 2023-12-09.

Share this article:

This article uses material from the Wikipedia article SRL_Diagnostics, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.